These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2572002)

  • 1. Effects of the putative anxiolytic SM-3997 on central monoaminergic systems.
    Tatsuno T; Shimizu H; Hirose A; Tanaka H; Kumasaka Y; Nakamura M
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1049-55. PubMed ID: 2572002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
    Fuller RW; Perry KW
    J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission.
    McMillen BA; Scott SM; Williams HL; Sanghera MK
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):454-64. PubMed ID: 2439924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SM-9018, a potential atypical neuroleptic, on the central monoaminergic system in rats.
    Maruoka Y; Ohno Y; Kato T; Hirose A; Tatsuno T; Nakamura M
    Jpn J Pharmacol; 1993 Aug; 62(4):419-22. PubMed ID: 7901446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--II. Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenergic neurotransmission.
    Blier P; Curet O; Chaput Y; de Montigny C
    Neuropharmacology; 1991 Jul; 30(7):691-701. PubMed ID: 1681447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
    Hamon M; Fattaccini CM; Adrien J; Gallissot MC; Martin P; Gozlan H
    J Pharmacol Exp Ther; 1988 Aug; 246(2):745-52. PubMed ID: 2457083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
    Koenig JI; Meltzer HY; Gudelsky GA
    Pharmacol Biochem Behav; 1988 Apr; 29(4):711-5. PubMed ID: 2901112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of SM-3997: a new anxioselective anxiolytic candidate.
    Shimizu H; Hirose A; Tatsuno T; Nakamura M; Katsube J
    Jpn J Pharmacol; 1987 Dec; 45(4):493-500. PubMed ID: 2895201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover.
    Ballarín M; Carceller A; Guitart X
    Br J Pharmacol; 1994 Oct; 113(2):425-30. PubMed ID: 7530571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a postsynaptic action of the serotonergic anxiolytics: ipsapirone, indorenate and buspirone.
    Fernández-Guasti A; López-Rubalcava C; Pérez-Urizar J; Castañeda-Hernández G
    Brain Res Bull; 1992 Apr; 28(4):497-501. PubMed ID: 1352175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of 5-hydroxytryptaminergic and dopaminergic mechanisms in the eating induced by buspirone, gepirone and ipsapirone.
    Fletcher PJ; Davies M
    Br J Pharmacol; 1990 Mar; 99(3):519-25. PubMed ID: 2139586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of midazolam and buspirone on in vivo concentration of amino acids and monoamine metabolites in the rat hippocampus.
    Wisłowska-Stanek A; Hamed A; Lehner M; Bidziński A; Turzyńska D; Sobolewska A; Walkowiak J; Płaźnik A
    Pharmacol Rep; 2008; 60(2):209-18. PubMed ID: 18443382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of nomifensine on in vivo uptake and metabolism of dopamine, noradrenaline and serotonin in the rat brain.
    Broch OJ
    Pharmacol Toxicol; 1987 Jan; 60(1):70-4. PubMed ID: 3562394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.
    Eison AS; Eison MS; Stanley M; Riblet LA
    Pharmacol Biochem Behav; 1986 Mar; 24(3):701-7. PubMed ID: 2871564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical anxiolytic profile of buspirone and a related drug, SM-3997, in a modified forced swim test employing straw suspension.
    Nishimura H; Tanaka M; Tsuda A; Gondoh Y
    Pharmacol Biochem Behav; 1993 Nov; 46(3):647-51. PubMed ID: 7904073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of SM-3997 with serotonin receptors in rat brain.
    Shimizu H; Karai N; Hirose A; Tatsuno T; Tanaka H; Kumasaka Y; Nakamura M
    Jpn J Pharmacol; 1988 Mar; 46(3):311-4. PubMed ID: 2898033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A agonists uncouple noradrenergic somatodendritic impulse flow and terminal release.
    Broderick PA; Piercey MF
    Brain Res Bull; 1991 Nov; 27(5):693-6. PubMed ID: 1684526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats.
    Pandaranandaka J; Poonyachoti S; Kalandakanond-Thongsong S
    Physiol Behav; 2006 Apr; 87(4):828-35. PubMed ID: 16545402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the effects of buspirone, BMY 13805, and 1-PP on dopaminergic metabolism in the nucleus accumbens using in vivo voltammetry in freely moving rats.
    Louilot A; Le Moal M; Simon H
    Life Sci; 1986 Aug; 39(8):685-92. PubMed ID: 2874469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.